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Muscle tone of coronary arteries is regulated by free
calcium concentration in the myoplasm. Various ago-
nists, autacoids and putative peptides modify the calcium
concentration directl y or through actions of second mes-
sengers (signal transductors), such as cyclic guanosine
monophosphate (GMP), cyclic adenosine monophos-
phate (AMP), inositol 1,4,5·trisphosphate, diacylgly-
cerol or calmodulin. For example , acetylcholine (in the
presence of intact endothelium cells), alpha-human na-
triuretic peptide or nitrate compounds increase the amount
of cyclic GMP and isoproterenol , prostacyclin (prosta-
glandin 12) or vasoactive intestinal polypeptide increases
cyclic AMP. Both cyclic nucleotides reduce free calcium
Calcium Homeostasis in Vascular Smooth
Muscles in Relation to the Contraction-
Relaxation Cycle
The contraction-relaxation cycle in vasc ular smooth mus-
cle is regulated by changes in free myoplasmic ca lcium
concentration. Increa sing calcium concentration up to 0 . 1
J-tM activa tes the contractile mach inary whereas lower ing
concentration relaxes the tissue (1,2). The exact level of
myoplasmic calcium needed to activa te vasc ular smooth
muscle depends on the calci um sensitivity of the contractile
proteins (3) .
Mechanisms of increased intracellular calcium. Free
myoplasmic ca lcium concent rat ion can be increased by cal-
cium influx across the plasma membrane or by release of
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concentration. On the other hand , acetylcholine (in the
presence or absence of endothelium cells), norepineph-
rine or thromboxane A2 increases inositol 1,4,5-tris -
phosphate and diacylglycerol, thus causing the increase
in the free calcium concentration, whereas vasoactive
intestinal peptide and alpha-human natriuretic peptide
reduce them. Calmodulin acts as an internal calcium
receptor for regulation of the contractile machinary.
Regulation of calcium homeostasis in relation to the mus-
cle tone in the coronary arteries including other vascular
tissues is discussed together with the role of second mes-
sengers.
(J Am Coil Cardiol1987,'9:Jl67-75)
calcium from intracellular storage sites, mainly the sarco-
plasmic reticulum (4), or both . At present, there appear to
be four basic mechanisms by which intracellular calcium
concentration can be increased :
1) Passive calcium influx . which involves simple diffu-
sion of calci um across the plasma membrane throu gh a
concentratio n gradient; the extracellular ca lcium concentra-
tion of I to 2 mM is much higher than the intracellul ar
calcium concentration, which is in the micromolar range .
2) Calcium influx through voltage-dependent plasma
membrane channels that open in response to membrane
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Figure 1. Regulation of contractile proteins in vascular smooth
muscles. ADP = adenosine diphosphate; ATP = adenosine tri-
phosphate; Ca = calcium; MLCK = myosin light chain kinase;
myosin-® = phosphorylated myosin; Pi = inorganic phosphate.
Ca2+4 - calmodulin
MLCK .0.. MLCK
(inactive) - (active)
vasoconstrictors and vasodilators through actions of, for
example,alpha-andbeta-adrenoceptor agonistsand nitrates.
This article describes the regulation of coronary artery tone
through the actions of signal transductors that regulate cal-
cium homeostasis.
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Regulation of Coronary Artery Tone
What triggers contraction in vascular smooth muscle?
(Fig. 1). Activation of the contractile proteins in vascular
smooth muscle is thought to begin when calcium binds to
the regulator protein, calmodulin. The binding of four cal-
cium ions to calmodulin induces a conformational change
in the calmodulin molecule that allows the calcium-cal-
modulin complex to interact with the inactive apoenzyme
of an enzyme called myosin light chain kinase. The active
ternary complex: calcium.-calmodulin-myosin light chain
kinase formed in this reaction then catalyzes the phospho-
rylation of the smooth muscle myosin light chain. Phos-
phorylation of myosin light chain enables the myosin mag-
nesium-A'TPase enzyme to interact with actin, resulting in
cross-bridge formation and contraction. Reduction in my-
oplasmic free calcium concentration by any of the mecha-
nisms described here dissociates the calcium-calmodulin
complex, which in turn dissociates calmodulinfrom myosin
light chain kinase, thereby regenerating the inactive apoen-
zyme of the latter enzyme. As a result, myosin phospho-
rylation ceases, myosin light chain is dephosphorylated by
a myosin light chain phosphatase and the muscle relaxes
(3,17-19).
Although most investigations support the view that myosin
phosporylation is the first step in smoothmusclecontraction,
depolarization or generation of an action potential. In some
vascular tissues (for example, the myogenic and resistance
vessels), action potentials resulting from calcium influx can
be evoked by nervestimulationunderphysiologic conditions
(5,6).
3) Calcium influx through receptor-operated plasma
membrane channels that open in response to the interaction
of agonists with specific receptors. Such interactions may
also increase membranesodium permeability, therebycaus-
ing membrane depolarization, which initiates a voltage-de-
pendent calcium influx.
4) Intracellular calcium release. Agonist-induced recep-
tor activation may also trigger calcium release from the
sarcoplasmic reticulum. In skeletal and cardiac muscles,
calcium release from the sarcoplasmic reticulum is thought
to be initiated by activation of voltage-dependent calcium
release and calcium-induced calcium release mechanisms
(7,8). A voltage-dependent calcium release in smooth mus-
cle has not been clearly shown, but receptor-operated and
calcium-induced calcium release mechanisms seem to play
a definite role (4,9).
Reduction in free myoplasmic calcium. Smooth mus-
cle relaxation is brought about by a reduction in free my-
oplasmic calcium concentrationcaused largelyby an active,
adenosine triphosphate (ATP)-dependent,calciumextrusion
mechanism (calcium pump) associated with the activation
of a calcium-adenosine triphosphatase (ATPase) (10). This
is in contrast to the sodium-calcium exchange diffusion
mechanism thought to be more important than the calcium
pump for reducing free myoplasmic calcium concentration
in cardiac muscle. The sodium-calcium exchanger utilizes
the potential energy produced by sodium influx down its
concentration gradient rather than energy produced by ATP
hydrolysis (11,12). In cardiac and smooth muscles, my-
oplasmiccalcium is also reduced by the reuptakeof calcium
intocellular stores, mainly thesarcoplasmic reticulum, through
an ATP-dependent calcium transport mechanism (13).
Drugs that influence calcium movements. A wide va-
riety of drugs influence the calcium movements that regulate
the contraction-relaxation cycle in smooth muscle. For ex-
ample, voltage-dependent calcium influx can be increased
by the calcium "agonists" Bay K-8644, YC-170 or CGP
28392 and can be inhibited by calcium channel blockers
like nifedipine, verapamil and diltiazem (14,15). Receptor-
operated calcium influx can also be activated by agonists
that bind to several receptors, such as adrenergic agonists,
and inhibited by the correspondingantagonists. The release
of calcium from smooth muscle sarcoplasmic reticulum is
accelerated by a newly discovered intracellular messenger,
inositol I ,4,5-trisphosphate (16) as well as by caffeine, and
can be inhibited by procaine. A number of signal transduc-
tors (second messengers) are involved in calcium homeo-
stasis, including calcium, cyclic nucleotides and inositol
trisphosphate, which mediate the actions of coronary
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some unsolved problems remain. For example, when po-
tassium chloride or an agonist is applied to smooth muscle
for long periods of time, sustained contractions are seen
despite marked reduction of myosin light chain phospho-
rylation. This finding may reflect a second calcium-depen-
dent regulatory mechanism that enables nonphosphorylated
myosin cross bridges to maintain the interactions between
myosin and actin, and so sustain contraction. These non-
phosphorylated myosin cross bridges exhibit slow cross-
bridge cyclings that have been termed" latch bridges" (17).
These findings, therefore, suggest the existence of a dual
activation mechanism in which increased free calcium con-
centration first activates myosin light chain kinase, whieh
phosphorylates myosin and leads to rapid cross-bridge cy-
cling. Myoplasmic calcium concentration then declines to
a value intermediate between the peak and rest levels, at
which myosin light chain kinase is inactivated and myosin
light chain-phosphatase dephosphorylates myosin. How-
ever, contraction is maintained, possibly by a second cal-
cium-dependent regulatory mechanism having a higher cal-
cium sensitivity than that of the myosin light chain kinase
system. Recent measurements of myoplasmic free calcium
concentration indicate that calcium levels remain high dur-
ing a potassium-induced contraction, but decline rapidly
after the appearance of a transient peak in contraction in-
duced by agonistsor caffeine (20,21). However, the detailed
relation between free calcium concentration and the force
of contraction remains to be clarified.
How do nitrates relax coronary vascular tissue? Ni-
troglycerin, sodium nitroprusside and isosorbide dinitrate
are well known to dilate vascular smooth muscle. Nitrates
are more potent in relaxing venous than arterial strips (22);
these observations have been confirmed using blood flow
measurements in vivo (23). Angiographicobservations sup-
port the view that nitroglycerin also causes vasodilation of
spastic regions inexperimental animalsand patients (24,25).
Nitrates relax coronary artery strips precontracted by
voltage-dependent (high potassium concentrations) or re-
ceptor-operated calcium influx (norepinephrine or acetyl-
choline) (5,26,27). Because the causes of angina pectoris
are multifactorial, such nonselective relaxation may be of
more value in alleviating anginal pain than that caused by
more selective drugs such as calcium channel blockers that
act principally on the voltage-dependentcalcium influx. The
nitrates apparently do not act on receptors or calcium chan-
nels at the surface of the myoplasmic membrane, and they
do not act directly on the sarcoplasmic reticulum of "skinned"
smooth muscles prepared by disrupting the myoplasmic
membrane with detergents (4). Nitrates do not appear to act
directly on the myoplasmic membrane, but instead may
modify the production of substances that regulate my-
oplasmic calcium homeostasis. One such substance is cyclic
guanosine monophosphate (GMP), whose concentration in
vascular tissues is increased by nitrates. Exogenously ap-
plied dibutyryl cyclic GMP, a permeablederivativeof cyclic
GMP, has much the same action on intact muscle tissues
as does nitroglycerin (27). However, nitrates do not modify
the amount of cyclic adenosine monophosphate(AMP) (27),
the metabolism of phosphatidyl inositol 4,5-bisphosphate
or the amounts of diacylglycerol and inositol trisphosphate
in vascular smooth muscles (27-29).
Role of cyclic GMP in relation to smooth muscle re-
laxation. Increasedcyclic GMP concentrations in such vas-
cular smooth muscles as coronary arteries activates a cyclic
GMP-dependentprotein kinase (G-kinase) that catalyzes the
phosphorylation of several proteins. This, in turn, leads to
relaxation of precontracted smooth muscle by the following
mechanisms: I) Cyclic GMP activates a G-kinase that phos-
phorylates myosin light chain kinase, thereby inhibiting the
phosphorylation of myosin light chain induced by the cal-
cium-calmodulin-myosin light chain kinase complex
(27,30,31). 2) The G-kinase activated by cyclicGMP through
another phosphorylation reaction accelerates the calcium
pump of the smooth muscle plasma membrane, thereby
leading to a reduction in myoplasmic free calcium concen-
tration (32).3) Although G-kinase activated by cyclic GMP
does not appear to modify calcium accumulation into sar-
coplasmic reticulum storage sites, it may slightly inhibit
calcium release from them (1,27). These observations in-
dicate that the activation of G-kinase by cyclic GMP produced
in response to the nitrates reduces myoplasmic free calcium
concentration, directly inhibits the contractile proteins and,
perhaps most important, accelerates active calcium extru-
sion from the myoplasm.
Cyclic GMP levels in smooth muscle can also be in-
creased by atrial natriureticpeptideand endothelium-derived
(dependent) relaxing factor (33-35). Nicorandil (2-nicoti-
neamideethylnitrate), a new antianginal agent that possesses
actions similar to those of nitrates (36,37), also increases
cyclic GMP levels (38). Unlike nitroglycerin and isosorbide
dinitrate, this agent hyperpolarizes the plasma membrane
by opening calcium-independent potassium channels
(36,37,39). Therefore, this drug acts on coronary vascular
smooth muscle in a mannerdifferent from that of the calcium
antagonists and other nitrates.
Why do beta-adrenoceptor agonists have a cardio-
tonic action on cardiac muscle but a vasodilating action
on the coronary artery? Activation of the betayadreno-
ceptors of visceral smooth muscles by catecholamines such
as isoproterenol, epinephrine and norepinephrine leads to
relaxation by a response that is thought to be mediated by
cyclic AMP. After treatment with alpha-adrenoceptorblock-
ing agents, the beta--adrenoceptor agonists block the gen-
eration of spike potentials and may hyperpolarize the my-
oplasmic membrane in various visceral muscle cells (5,40);
however, these catecholamines consistently cause smooth
muscle relaxation in the presence of alpha-adrenoceptor
blocking agents. This relaxing effect is accompanied by
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increased levels of cyclic AMP with no significant change
in cylic GMP levels (27).
The relaxing effects of cyclic AMP are believed to be
mediated by activation of a cyclic AMP dependent protein
kinase (A-kinase) by the following mechanisms (Fig. 2): I)
Activated A-kinase phosphorylates myosin light chain ki-
nase in a manner similar to that of G-kinase, thereby causing
the muscle to relax by inhibiting the phosphorylation of
myosin (3,17-19,27). 2) Activated A-kinase enhances cal-
cium accumulation by the sarcoplasmic reticulum (27,32).
3) Activated A-kinase accelerates calcium extrusion by the
plasma membrane calcium pump (32).
These effects of activated A-kinase are thus similar to
those of activated G-kinase except that these two cyclic
nucleotide-dependent protein kinases differ with regard to
their effects on calcium accumulation into the sarcoplasmic
reticulum. Calcium accumulation is stimulated by A-kinase
but not by G-kinase, so that nitroglycerin reduces the amount
of calcium stored in the sarcoplasmic reticulum but increases
calcium storage in these intracellular membranes (27).
Exogenously applied dibutyryl cyclic AMP, a permeable
derivative of cyclic AMP that has essentially the same ef-
fects as isoproterenol (27), and intracellularly applied cyclic
AMP do not modify the amplitude of the inward calcium
current in visceral smooth muscles (41). These effects differ
from the well known effects of beta-adrenocepror activa-
tion, intracellularly applied cyclic AMP and extracellularly
applied dibutyryl cyclic AMP to increase voltage-dependent
calcium influx in cardiac muscle.
These findings indicate that the beta-adrenoceptor block-
ers (which indirectly inhibit the effects of A-kinase de-
scribed) do not prevent angina pectoris by acting directly
as coronary vasodilators; rather, they inhibit vasodilation.
Thus, their antianginal effects arise from their negative ino-
tropic and chronotropic actions, which reduce cardiac ox-
ygen consumption, their ability to reduce renin secretion
and angiotensin II synthesis (42) and their inhibitory actions
on the vasomotor center in the central nervous system (43).
Relation of Inositol Phospholipid to Receptor-
Operated Calcium Release From the
Sarcoplasmic Reticulum
Inositol trisphosphate and calcium release (Fig. 2).
Smooth muscle contraction can occur without a significant
change in membrane electrical properties and in the absence
of extracellular calcium. Such contractions are generated by
release of calcium from the sarcoplasmic reticulum by a
process known as pharmacomechanical coupling (1,2,44).
The manner in which the activated receptors trigger calcium
release has recently been explained by the discovery of a
new second messenger, inositol trisphosphate (16,45,46)
(Fig. 2). This substance is derived from inositol phospho-
lipids in the membrane; these include phosphatidylinositol
and its phosphorylated derivatives phosphatidylinositol 4-
phosphate and phosphatidylinositoI4,5-bisphosphate. In re-
sponse to receptor activation, phosphatidyl inositol bis-
phosphate (PI-Pz) is rapidly hydrolyzed to form inositol
trisphosphate and diacylglycerol. When a receptor binds to
its specific agonist, a phosphodiesterase (phospholipase C),
is stimulated to hydrolyze phosphatidyl inositol bisphos-
A23187
PI PIP
extracellular signal
OG
sarcoplasmic reticulum
PA
Ca2+ ATPase
PMA,OAG
extracellular space
plasma membrane
cytoaol
Figure 2. Transmembrane signaling
by way of the turnover of inositol
phospholipids. A23187 = a calcium
ionophore; ATPase = adenosine tri-
phosphatase; Ca = calcium; CaM =
calmodulin; CDP = cytidine diphos-
phate; C-kinase = cyclic AMP-de-
pendent protein kinase C; CMP = cy-
tidine 5' -monophosphate; DG =
diacylglycerol; GTP = guanosine 5'-
triphosphate; InsP, InsPz, InsP3 =
inositol 1- or 4-monophosphate, ino-
sitol 4-bisphosphate, inositol 1,4,5-
trisphosphate, respectively; OAG =
l-oleyl-2-acetyl glycerol; OH = hy-
droxy residue; ® = energy rich phos-
phate; PA = phosphatidic acid; PDE
= phosphodiesterase (phospholipase
C); PI, PIP, PIPz = phosphatidyl-
inositol, phosphatidylinositol 4-mon-
ophosphate, phosphatidylinositol 4,5-
bisphosphate, respectively; PMA
phorbol 12-myristate 13-acetate.
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phate to form inositol trisphosphate and diacylglycerol (Fig,
2). Subsequently, inositol trisphosphate is convertedto ino-
sitol through inositol bisphosphate and inositol phosphate
by stepwise dephosphorylations induced by activation of
individual phosphatases. The breakdown of inositol tris-
phosphate is accelerated by calcium concentrations up to I
p.,M, the maximal free calcium concentration found in the
myoplasm (47). In a parallel reaction, diacylglycerol kinase
forms phosphatidic acid from diacylglycerol and ATP, and
phosphatidic acid can then be converted to cytidine di-
phosphate-diacyl glycerate in the presence of cytidine tri-
phosphate. Activation of the enzyme cytidine diphosphate-
diacylglycerol-inositol phosphatidate transferase allows
phosphatidyl inositol to be synthesized from cytidine di-
phosphate-diacylglycerol and inositol. Phosphatidyl inositol
is then phosphorylated to produce phosphatidyl inositol
monophsphate and phosphatidyl inositol bisphosphate by
the actions of specific kinase (Fig. 2).
Our present knowledge of the effects of agonist-induced
phosphatidyl inositol bisphosphate hydrolysis on calcium
homeostasis in vascular smooth muscles can be summarized
as follows .. I) In the porcine coronary artery and in rabbit
and dog mesenteric arteries, both acetylcholine and nor-
epinephrine reduce phosphatidyl inositol bisphosphate and
increase phosphatidic acid and 3H-inositol-labeled inositol
trisphosphate. These actions of acetylcholine and norepi-
nephrineare inhibitedby atropineand prazosin, respectively
(48). 2) In these vascular smooth muscles, both acetylcho-
line and norepinephrine can produce a contraction in cal-
cium-free solution (2). 3) Inositol trisphosphate causes cal-
cium release from isolated sarcoplasmic reticulumfraction,
but only a small calcium release from porcine coronary
artery smooth muscle sarcolemma (49).4) In porcine coro-
nary arteries inositol trisphosphate releases calcium from
skinned muscles and dispersed single muscle cells. 5) Ap-
plication of inositol trisphosphate produces contractions in
skinned porcine coronary and rabbit mesenteric arteries. 6)
Breakdown of inositoltrisphosphate to inositol bisphosphate
by inositol trisphosphatase is stimulated by increasing cal-
cium concentration (47), and inositol trisphosphatase activ-
ity is enhanced by the activation of C-kinase in porcine
coronary arteries. These observations indicate that inositol
trisphosphate, hydrolyzed from phosphatidyl inositol bis-
phosphate by the activation of phosphodiesterase, is a phys-
iologic second messenger for the agonist-receptor-induced
release of calcium from sarcoplasmic reticulum in vascular
smooth muscle.
Diacylglyceroland protein kinase C. The other product
of phosphatidyl inositol, diacylglycerol, activates another
protein kinase, C-kinase, in the presence of both calcium
and phosphatidylserine (50). These effects of diacylglycerol
can also be produced by a class of carcinogens called phor-
bol esters (12-0-tetradecanoylphorbol-13-acetate (TPA) or
phorbol 12-myristate-13-acetate) (50).
Activation of C-kinase leads to the phosphorylation of
various proteins in vascular tissue (51) including a 20 kDa
protein of myosin light chain. C-kinase is found mainly in
the cytoplasm, but when this enzyme is activated, it is
concentrated in the sarcolemma by a translocation process
(50,52,53); the importance of this translocation in vascular
smooth muscles to inhibit the contraction has not been es-
tablished. Whereas TPA in high concentrations has inhib-
itory actions on the contractile proteins (51), acetylcholine
and norepinephrine have excitatory actions on the mechan-
extracellular
.--- / signals~ .--- _
A kinase I
+protein phosphorylation
+cellular response
Figure3. Transmembrane signaling by
way of the adenylate cyclase system.
ADP = adenosine 5/-diphosphate; A-
kinase = cyclic AMP-dependent pro-
tein kinase A; AMP = adenosine mon-
ophosphate; ATP = adenosine triphos-
phate; cAMP = cyclic AMP; GOP =
guanosine diphosphate; Gi, Gs = in-
hibitory, stimulatory GTP binding pro-
tein, respectively; GTP = guanosine
triphosphate; lAP = islet activating
protein (pertussis toxin); NAD = nico-
tinamide adenine dinucleotide; Ns = Gs;
Ni = Gi; Pi = inorganic phosphate.
"'0~~o
cholera t-Q'<
toxiny
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+
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Figure 4. Interaction between main pathways of
signal transductions. A-, C- andG-kinases = cyclic
AMP-dependent protein kinase A, protein kinase
C and cyclic GMP dependent protein kinase G,
respectively; cGMP = cyclic guanosine mono-
phosphate; RA = adenylatecyclase activating re-
ceptor; Rc = phosphodiesterase (phospholipase
C) activating receptor; RG = guanylate cyclase
activating receptor; other abbreviations as in Fig-
ures2 and 3. Bidirectional ( - ) and nondirectional
(+ ) control systems.
ical properties in porcine coronary and rabbit mesenteric
arteries, respectively. Therefore, inositol trisphosphate, rather
than the C-kinase system, seems to playa major role in the
initiation of contraction (54).
Inositol trisphosphate- and calcium-induced calcium
release mechanism in vascular tissues. In vascularsmooth
muscle, depolarization of the plasma membrane directly
increases free myoplasmic calcium concentration by acti-
vation of voltage-dependent calcium influx. Although the
amount of calcium influx calculated from measurements of
the calcium inward current is enough to fully activate the
contractile proteins, the calcium that enters the cell by this
mechanism does not directly activate the contractile pro-
teins. Instead, this calcium is sequestered in a storage site
of the sarcoplasmic reticulum from which it can be released
when a calcium-induced calcium release mechanism is trig-
gered by inositol trisphosphate.
The previously described mechanism appears to activate
the contractile proteins (4, JJ,26,31) for the following rea-
sons: I) Procaine inhibits both contractions and calcium
releasefromsmoothmusclesarcoplasmic reticulumbutdoes
not inhibit the action potential. Thus, procaine uncouples
electricalfrommechanical activity. 2) Procainehas nodirect
effect on contractile proteins as estimated from calcium-
induced contraction in skinned smooth muscle tissue. 3)
After depletion of calcium stores in depolarized vascular
smoothmuscletissue, additionof calcium initially increases
calcium accumulation into sarcoplasmic reticulumand only
subsequently causes contraction. 4) In skinned vascular smooth
muscle tissues, calcium accumulation into the sarcoplasmic
reticulum is increased in direct proportion to appliedcalcium
below 1.0 JLM; further increases in calcium concentration
reduce the amount of calcium stored because of calcium-
induced calcium release.
Only one-third of the stored calcium is released from
fragmented sarcoplasmic reticulum by high concentrations
of inositol trisphosphate (10 to 20 JLM). However, in intact
vascularsmoothmuscletissues, nearlyall the storedcalcium
Table 1. Effects of Various Agents on Contraction and Relaxation of Visceral Smooth Muscles
in Relation to Second Messengers
Membrane Contraction Secondary
Potential Relaxation Messenger
ACh Depo., Hyper.. No change Contraction PI-P, +
(cGMP +)
NAd(a!l Depo., No change Contraction PI-P, +
NAd (a,) Depo. Contraction cAMP
ISOP Hyper., No change Relaxation cAMP +
a-hANP No change Relaxation cGMP +
PI-P,
VIP No change Relaxation cAMP +
PI-P,
TXA, No change. Depo. Contraction PI-P, +
EDRF Hyper.. No change Relaxation cGMP +
(pl-P, -)
In the case of acetylcholine, cyclic guanosine monophosphate (GMP) is increased in the presence of
endothelium; in the case of endothelium-derived relaxing factors (EDRF), phosphat idyl inositol bisphosphate
(PI-P2) is reduced after amounts of cyclic GMP are increased. ACh = acetylcholine; cAMP = cyclic adenosine
monophosphate; depo. = depolarization; hANP = human atrial natriuretic peptide; hyper. = hyperpolarization
of myoplasmic membrane; ISOP = isoprenaline; TXA2 = thromboxane A2; VIP = vasoactive intestinal
peptide.
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seems to be released by high concentrations of agonists
(26.54,55). Thus, the calcium released by inositol tris-
phosphate may accelerate or trigger a larger calcium-in-
duced calcium release from sarcoplasmic reticulum to produce
a large contraction in vascular smooth muscle.
Do individual signal transductors (second messen-
gers) act independently or do they interact in the reg-
ulation of cellular vascular smooth muscle activity? We
have seen how neurotransmitters can have multiple actions
on vascular smooth muscles by promoting the synthesis of
such signal transductors as cyclic AMP, cyclic GMP and
inositol trisphosphate. Acetylcholine applied exogenously
to excised coronary arteries can generate a variety of re-
sponses in smooth muscle from different species; in the
guinea pig coronary artery. acetylcholine hyperpolarizes the
myoplasmic membrane and increases calcium-dependent
potassium permeability. In the rabbit coronary artery. ace-
tylcholine depolarizes the myoplasmic membrane and in-
creases sodium permeability (55), but in the porcine coro-
nary artery, it has no effect on membrane potential and
resistance (5,9). However, in all these tissues, acetylcholine
produces a contraction that is blocked by atropine. There-
fore, the mechanisms of action of the same agonist differ
in different species (2).
Acetylcholine accelerates PI-P 2 breakdown and in-
creases production o] inositol trisphosphate . Stimulationof
the alpha.vadrenoceptor by norepinephrine also accelerates
PI-P1 breakdown with or without depolarization of the my-
oplasmic membrane, whereas alpha--adrenoceptor agonists
inhibit synthesis of cylic AMP and have no effect on PI-P,
turnover. Previously, the alpha- adrenoceptor was though;
to be distributed on prejunctional nerve terminals and to act
as a negative feedback controller on transmitter release at
nerve terminals. However, the alphayadrenoceptor is also
distributed on the plasma membranes of both arteries and
veins (56). Stimulation of both beta,- and beta-adrenocep-
tors increases cyclic AMP. Cyclic AMP production is in-
hibited by cholera toxin and stimulated by pertussis toxin
(Fig. 3) through adenosine diphosphate-ribosylation of
guanosine triphosphate-binding regulatory proteins that are
found in the plasma membranes (57.58).
In general , the A- , G- and Cikinase systems (including
inositol trisphosphate) play an important role in the tran s-
membrane control process of calcium homeostasis in man v
types of vasc ular smooth muscle. However, these systems
do not seem to act independently of each other. One system
potentiates the effect of the other in pancreatic islet cells
(monodirectional control system), whereas one inhibits the
other in lymphocytes and neutrophils (bidirectional control
system) (50) (Fig. 4). The A-, G- and C-kinases are dis-
tinctly different in their catalytic functions, but may interact
at the level of their target proteins in vascular tissues; for
example, activation of peptide receptors modulate second
messenger systems to modify thecontraction-relaxation cycle.
Clinical Implications
Contractionand relaxation of visceral smooth muscle are
mediated by second messengers that are generated in re-
sponse to various neurotransmitters and autacoids (Table 1).
The actions of vasodilators. such as nitrates, alpha- and
beta-adrenoceptor agonists and blocking agents. and some
peptide hormones have been briefly described in terms of
the actions of signal transductors like cyclic nucleotides,
inositol trisphosphate and diacylglycerol on calcium mo-
bilization and homeostasis.
Muscle tone in coronary arteries can be regulated by
many factors. so that the causes of vasospastic angina are
probably multifactorial. Neurogenic , myogenic, humoral and
endothelium-derived factors can generate a variety of mes-
sengers that may contribute differently from one patient to
another. Advances in these areas have been rapid and re-
markable. but even though calcium homeostasis in smooth
muscle is now better understood, most of the results de-
scribed in this review introduce more complications than
clarifications. More detailed and intense investigations at
cellular or molecular levels are needed to explain the phys-
iologic and pathophysiologic states of the coronary artery
smooth muscle tone.
We thank A. H. Weston. PhD for critical reading of the manuscript.
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